Lepik K, Mikhailova N, Kondakova E, et al. Nivolumab for treatment of patients with relapsed/refractory classical Hodgkin’s lymphoma (CHL): clinical and patient-reported outcomes. 24th Congress of EHA, abstract PS1239.
‘Risicomodel IPSS-M dient standaard te worden gebruikt bij MDS’
okt 2023 | MDS, Stamceltransplantatie